Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 13, 2026
Chime Financial (CHYM) Stock Climbs +50.8% in 30 Days After Earnings Surprise

Chime Financial (CHYM) Stock Climbs +50.8% in 30 Days After Earnings Surprise

Key Takeaways

  • CHYM rose about 50.8% over the past 30 days, from a closing price of $20.95 on July 13, 2026, to $31.60 on August 12, 2026.
  • The advance was driven primarily by Chime's second-quarter 2026 earnings beat, a second consecutive GAAP profit, and raised full-year revenue guidance.
  • Shares jumped 20.6% on August 6, 2026, closing at $31.25 on volume of roughly 19.3 million shares, well above typical sessions.
  • Over the trailing three months, CHYM has climbed about 76.7%, from $17.88 on May 14, 2026, to $31.60 on August 12, 2026.
  • Several analysts raised price targets after the report, with post-earnings targets ranging from $28 to $45.

Chime Financial (CHYM) Company Overview and Market Position

Chime Financial, Inc. is a U.S.-based financial technology company that provides digital consumer banking and payment solutions. Its product ecosystem includes spending accounts, debit and credit cards, savings products, fee-free overdraft through SpotMe, the MyPay earned wage access service, Instant Loans, and the Chime Prime membership tier introduced in April 2026. In July 2026, the company launched Chime Invest, adding managed portfolios and self-directed brokerage to its app. Chime also operates a workplace banking unit, Chime Enterprise, which offers financial wellness tools and earned wage access to employers.

Chime's business model monetizes primary-account relationships through interchange, transaction fees, subscription revenue, and credit products. The company emphasizes its proprietary ChimeCore platform, which processes transactions and maintains ledgers internally to keep cost-to-serve low. Management cited a cost-to-serve of about $141 per customer, versus roughly $450 for large banks. In May 2026 survey data highlighted by the company, Chime captured about 14% of new checking account openings, and active members reached 10.4 million in the second quarter, up 20% year over year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CHYM Stock Price Performance: Last 30 Days vs. Quarter

From a closing price of $20.95 on July 13, 2026, CHYM advanced to $31.60 by the August 12, 2026 close, a gain of about 50.8% over 30 days. The move accelerated sharply after the August 5 earnings report: the stock closed at $25.92 on August 5 and then at $31.25 on August 6, a one-session gain of 20.6%. Intraday trading on August 6 reached $33.41, marking a 52-week high. After that spike, shares consolidated and closed at $31.60 on August 12, down 0.41% for the session.

The quarterly picture is even stronger. Three months earlier, on May 14, 2026, the stock closed at $17.88. The rise to $31.60 represents a gain of about 76.7%. The quarter was not a straight line: CHYM traded below $17 during parts of May and set a 52-week low of $15.88 on June 11 before recovering through late June and July and then breaking out on the earnings release.

What Drove CHYM Stock Price in the Last 30 Days

The primary catalyst was Chime's second-quarter 2026 results, reported on August 5. Revenue reached $669.8 million, up 26.8% year over year and above consensus estimates near $640.6 million. Adjusted EPS of $0.07 beat the consensus estimate of a $0.01 loss. GAAP net income was $28 million, the company's second consecutive quarter of positive GAAP earnings, and adjusted EBITDA reached $102 million, with the margin expanding to 15% from about 3% a year earlier.

Other operating metrics reinforced the story. Active members rose 20% year over year to 10.4 million, average revenue per active member increased 6% to $260, and transaction profit grew 36% to $492 million. MyPay originations totaled $4.5 billion with a loss rate of about 0.9%, while Instant Loan originations rose nearly 70% sequentially to $300 million. Management raised full-year revenue guidance to between $2.725 billion and $2.745 billion and announced a 10% workforce reduction intended to support operating leverage.

Analyst reaction amplified the move. Multiple firms raised price targets after the report, including Canaccord Genuity to $45, Evercore ISI to $39, B. Riley to $37, and several others to between $32 and $35. The overall consensus remained a Moderate Buy, but the revisions signaled rising confidence in Chime's profitability trajectory. Enterprise wins, including a workplace banking agreement with Allied Universal and a national retailer, and the July launch of Chime Invest added to the growth narrative. Some executives also disclosed stock sales under pre-arranged Rule 10b5-1 plans during the post-earnings strength, which added supply but did not reverse the advance.

What Drove CHYM Stock Performance Over the Last Quarter

The broader three-month trend reflects a shift in how investors are valuing Chime: from a high-growth, cash-burning fintech toward a business demonstrating repeatable profitability. The April launch of Chime Prime, aimed at higher-income members with at least $3,000 in monthly direct deposits, became a central growth driver. Management said Prime members generate more than twice the revenue per active member of the average member. Meanwhile, MyPay and Instant Loans scaled with disciplined loss rates, supporting transaction-margin expansion.

During May and early June, the stock was under pressure, touching a 52-week low of $15.88 on June 11. Sentiment improved through the summer as enterprise partnerships were announced, Chime Invest launched, and Wall Street began raising targets. The August earnings report then confirmed the operating leverage story, producing the sharp re-rating that pushed the trailing-quarter gain to roughly 77%.

CHYM Stock Forecast Drivers: What Investors Should Watch Next

Investors monitoring CHYM should track the rollout of new products and the sustainability of the profitability inflection. Chime said it expects Instant Loans to exit the third quarter at an annualized revenue run rate above $100 million and plans to begin beta testing a revolving line of credit for Prime members. Management also began raising MyPay limits to as much as $1,000, which could modestly lift loss rates even as transaction profit rises. Sell-side estimates have pointed to full-year EPS of about $0.34 for 2026.

Macroeconomic conditions and consumer spending trends remain important, given Chime's reliance on interchange and transaction activity. Competitive pressure from other digital banking and fintech platforms, the pace of Chime Prime adoption, rewards costs, and execution of the ChimeCore migration will also influence sentiment. After the sharp run, valuation and insider 10b5-1 selling plans may attract more scrutiny, while analyst estimates will be updated as the company reports subsequent quarters. From what I see, these factors will shape the next leg of the move.

Exploring AI Tools for Trading Insights

I often review Tickeron’s Trending AI Robots page when analyzing names like CHYM. It offers a curated view of AI-driven bots across many tickers, helping compare strategies, timeframes, and risk profiles without focusing on just one approach. This fits naturally into my research process for understanding automated options alongside fundamental developments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CHYM

Momentum Indicator for CHYM turns positive, indicating new upward trend

CHYM saw its Momentum Indicator move above the 0 level on September 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator turned positive. In 17 of the 19 cases, the stock moved higher in the following days. The odds of a move higher are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +3.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHYM advanced for three days, in 50 of 63 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 35 of 43 cases where CHYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for CHYM moved out of overbought territory on September 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In 3 of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 6 of 9 cases where CHYM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.

The Moving Average Convergence Divergence Histogram (MACD) for CHYM turned negative on August 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 5 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHYM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

CHYM broke above its upper Bollinger Band on September 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CHYM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.066) is normal, around the industry mean (28.479). P/E Ratio (6.263) is within average values for comparable stocks, (76.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.588). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (5.291) is also within normal values, averaging (77.677).

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), ServiceNow Inc. (NYSE:NOW), Uber Technologies (NYSE:UBER), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.24B. The market cap for tickers in the group ranges from 291 to 249.24B. SAP holds the highest valuation in this group at 249.24B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 0%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 6%. FTFT experienced the highest price growth at 338%, while AIXI experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 58
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
CHYM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Industry
N/A
Address
101 California Street
Phone
+1 844 244-6363
Employees
1519
Web
https://www.chime.com
Interact to see
Advertisement
EVCM shares are plunging approximately 23% in premarket trading on March 13, 2026, following the company's Q4 2025 earnings release after the prior session's close. The primary catalyst is a significant EPS miss — EverCommerce reported adjusted EPS of $0.03, badly missing the consensus estimate of $0.05, a 40% negative earnings surprise.
ADBE shares are down approximately 8.67% in premarket trading on March 13, 2026, erasing gains from the prior session. The primary catalyst is the surprise announcement that longtime CEO Shantanu Narayen will step down after 18 years once a successor is named.
ULTA shares are declining sharply in premarket trading on March 13, 2026, extending losses that began after the company's earnings release after the close on March 12 — with the stock down approximately 8.3% in premarket, building on a -4.28% decline during the regular session on March 12. The primary catalyst is fiscal 2026 earnings guidance that fell short of Wall Street expectations, with the company projecting diluted EPS of $28.05–$28.55 against analyst consensus of approximately $28.58.
EONR is trading approximately +10% higher in Friday's premarket session, extending a powerful multi-day rally that has seen the stock surge over 250% year-to-date. The primary catalyst is the company's newly expanded oil hedging program, locking in favorable pricing through 2027 as oil prices spike amid geopolitical tensions in the Middle East.
Shares of El Pollo Loco Holdings (LOCO) surged approximately 15% in early trading on March 13, 2026, following a strong Q4 2025 earnings report released after the close on March 12. The company posted adjusted EPS of $0.25, beating the consensus estimate of $0.21 — a 20.95% earnings surprise — and the highest quarterly beat in recent history.
Shares of Resolute Holdings Management (RHLD) are declining approximately 10% in Friday's session, extending a sharp multi-session downtrend. The primary catalyst is a disappointing full-year and Q4 2025 earnings report released on March 12, 2026, which showed a widening net loss and a Q4 per-share loss of -$0.20 — worse than expectations.
Shares of BW are tumbling approximately 19% in early Friday trading, extending steep losses from the prior session. The primary catalyst is a short-seller report from Wolfpack Research, which publicly disclosed a short position in BW and raised serious questions about the company's flagship $2.4 billion deal.
Trading SOXL (the Direxion Daily Semiconductor Bull 3X ETF), one of the most volatile instruments in U.S. markets, the robot combines 15-minute pattern recognition with Financial Learning Models (FLMs) to extract alpha precisely when human traders are most likely to panic. In today's environment — where war headlines, rate uncertainty, and sector rotation collide — an AI that thrives on volatility isn't a luxury. It's an edge.
In only 6 trading days (March 6–12, 2026), this robot closed 40 trades with a staggering 97.50% win rate, generated $3,429.47 in net profit on $1K-per-trade sizing, and achieved an annualized return of 472.69% with a Profit Factor of 167.59. That is not a typo. While human traders were frozen in fear, this AI was executing with surgical precision — finding breakout entries across four of America's most iconic consumer brands and rotating capital at machine speed.
Gold Fields Ltd (GFI), one of the world’s largest gold producers with mines in Australia, Ghana, South Africa and the Americas, saw its U.S.-listed shares drop more than 10% today. The selloff comes less than a month after the company reported record 2025 profits and unveiled an aggressive capital‑spending and shareholder‑returns plan, and just as the stock trades ex‑dividend. Together, those factors triggered profit‑taking in a name that had rallied strongly into the results and dividend announcement.
ACDC fell over 11% today following the release of Q4 and full‑year 2025 results, reversing part of a roughly 35–40% rally the stock had staged since late 2025.
IPX fell over 14% today, compounding a similar‑sized decline in the previous session; the stock is now down roughly 24% over five days and back into negative territory year‑to‑date. The latest half‑year results showed continued operating losses of around US$34 million, highlighting the capital‑intensive and pre‑profit nature of IperionX’s titanium and critical‑minerals projects.
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.